CeriBell, Inc. financials

CBLL CIK 0001861107

Source: EDGAR filings · Built 2026-06-02T02:34:14Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2024
Free Cash Flow -41.58M -36.38M -30.14M
EBITDA -57.06M -38.57M -29.19M
Working Capital 167.53M 204.28M 30.36M
Net Debt -18.20M -172.41M -20.29M
Gross Margin 87.89% 86.72% 84.38%
Operating Margin -65.57% -60.68% -66.43%
Net Margin -59.97% -61.82% -65.15%
Return on Equity (ROE) -34.38% -21.16% 26.25%
Return on Assets (ROA) -27.28% -17.95% -50.01%
Current Ratio 9.73× 16.73× 2.41×
Debt-to-Equity 0.14× 0.11× -0.13×
Effective Tax Rate 0.00% 0.00% -0.04%
Cash Conversion Ratio 0.76× 0.87× 0.99×
Accruals Ratio -0.06× -0.02× -0.01×
SBC % of Revenue 13.72% 8.27% 5.92%
CapEx Coverage -53.20× -26.15× -29.66×
Free Cash Flow Per Share $-1.14 $-3.04 $-5.68

Valuation Metrics

Concept FY 2025FY 2024FY 2024
P/S 9.23× 14.18×
P/B 5.29× 4.85×

Income Statement

Concept FY 2025FY 2024FY 2024
Revenue from Contract with Customer, Excluding Assessed Tax 89.06M 65.44M 45.23M
Cost of Revenue 10.79M 8.69M 7.06M
Gross Profit 78.27M 56.75M 38.16M
Research and Development Expense 19.14M 13.56M 8.99M
Operating Expenses 136.68M 96.46M 68.20M
Operating Income (Loss) -58.40M -39.71M -30.04M
Income Tax Expense (Benefit) 0 0 11.00K
Net Income (Loss) Attributable to Parent -53.41M -40.45M -29.46M
Earnings Per Share, Basic $-1.46 $-3.39 $-5.56
Weighted Average Number of Shares Outstanding, Basic 36.54M 11.95M 5.30M
Earnings Per Share, Diluted $-1.46 $-3.39 $-5.56
Weighted Average Number of Shares Outstanding, Diluted 36.54M 11.95M 5.30M

Balance Sheet

Concept FY 2025FY 2024FY 2024
Cash and Cash Equivalents, at Carrying Value 40.48M 194.37M 34.49M
Assets, Current 186.72M 217.27M 51.96M
Assets 195.80M 225.41M 58.92M
Liabilities, Current 19.19M 12.99M 21.60M
Liabilities 40.47M 34.25M 23.76M
Stockholders' Equity Attributable to Parent 155.34M 191.16M -112.25M
Common Stock, Shares, Outstanding 37.49M 35.85M 5.43M

Cash Flow Statement

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (CBLL CIK 0001861107), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

CERT

Certara, Inc.

LCUT

LIFETIME BRANDS, INC.

STIM

NEURONETICS, INC.